PANTACIDO comprimés gastro-résistants 20 mg 14 pce

7680693760110 CH-69376 A02BC02 04.99.0.

Active substances:

No images available

Details

Product number
6937601
CPT
-
Packaging group
14
Unit
Tablette(n)
Composition
pantoprazolum 20 mg ut pantoprazolum natricum sesquihydricum, trinatrii phosphas anhydricus, isomaltum 29.25 mg, carmellosum natricum, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, povidonum K 25, propylenglycolum, E 171, E 172 (flavum), acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, dimeticonum, sorbitani stearas, polysorbatum 60, silica colloidalis anhydrica, xanthani gummi, E 210 <0.65 µg, E 200, kalii hydroxidum, acidum hydrochloridum, pro compresso obducto corresp. natrium 3.58 mg.

Articles (1)

Pantacido 20 mg, magensaftresistente Tabletten
Magensaftresistente Tabletten
14
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/04/2026
Patient information leaflet
Français
15/04/2026
Patient information leaflet
Italien
15/04/2026
Professional SmPC
Allemand
15/04/2026
Professional SmPC
Français
15/04/2026
Professional SmPC
Italien
15/04/2026

Detailed composition

Substance Quantity Type Category
pantoprazolum
20.0 MG Substance Wirkstoff (Principe actif)
pantoprazolum natricum sesquihydricum
- Substance WIZUS
trinatrii phosphas anhydricus
- Substance HNIDK
isomaltum
29.25 MG Substance HBESI
carmellosum natricum
- Substance HNIDK
crospovidonum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
hypromellosum
- Substance HNIDK
povidonum K 25
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
triethylis citras
- Substance HNIDK
dimeticonum
- Substance HNIDK
sorbitani stearas
- Substance HNIDK
polysorbatum 60
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
xanthani gummi
- Substance HNIDK
E 210
- Substance HBESI
E 200
- Substance Konservierungsstoff (Conservateur)
kalii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrium
3.58 MG Substance HBESI

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
69376
Drug name
Pantacido, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
A02BC02
Authorization status
Z
Dispensation category
D
First authorization
05/05/2023
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
kurzzeitige Behandlung von Refluxsymptomen bei Erwachsenen

Packaging details

Description (FR)
PANTACIDO comprimés gastro-résistants 20 mg 14 pce
Description (DE)
PANTACIDO magensaftresistente Tabl 20 mg 14 Stk
Market launch
15/04/2026
Narcotic (BTM)
No

Available generics

Panprax, magensaftresistente Tabletten
CHF 14.35
View
Panprax, magensaftresistente Tabletten
CHF 25.85
View
Panprax, magensaftresistente Tabletten
CHF 34.35
View
Panprax, magensaftresistente Tabletten
CHF 45.85
View
Panprax, magensaftresistente Tabletten
CHF 14.15
View
Panprax, magensaftresistente Tabletten
CHF 18.50
View
Panprax, magensaftresistente Tabletten
CHF 34.10
View
Panprax, magensaftresistente Tabletten
CHF 36.05
View
Panprax, magensaftresistente Tabletten
CHF 49.10
View
Pantoprazol axapharm, magensaftresistente Tabletten
CHF 14.10
View

Other packaging sizes

Buy us a coffee Explore the data